Generated by Meeveem AI
"Leading precision radiation therapy and adaptive radiotherapy for cancer care worldwide."
Elekta develops precision radiation therapy systems that help oncology clinics deliver personalized cancer treatment. For over 50 years, the company has made adaptive radiotherapy accessible, enabling clinicians to adjust treatment in real time as tumors and anatomy change. Technologies include linear accelerators, MR guided systems, planning software, and the Leksell Gamma Knife. Cancer patients and clinicians benefit from adaptive precision that preserves healthy tissue, reduces side effects, and improves outcomes across breast, prostate, brain, and gynecological cancers. Equitable access to high quality radiation therapy significantly impacts survival and quality of life for millions worldwide.
4500
Team Members
1972
Founded
Medical Devices
Sector
Hybrid
Work Environment
A world where every patient with cancer has access to the highest standard of precision care, regardless of location or resources.
At Elekta, our mission is to ensure every person with cancer has access to the best possible care through precision radiation therapy innovation.